Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 193-198

  Steinberg, Mitchell I ^a   Wiest, S A ^a   Pickard, R T ^a   Chen, K ^b   Shih, J C ^b  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 BENZOFURANYL 2 IMIDAZOLINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CIRAZOLINE; CLONIDINE; CLORGYLINE; COMPLEMENTARY DNA; GUANABENZ; IDAZOXAN; IMIDAZOLE DERIVATIVE; IMIDAZOLINE I2 RECEPTOR; MOXONIDINE; TRANYLCYPROMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; BINDING AFFINITY; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LIGAND BINDING; NONHUMAN; RAT; SCATCHARD PLOT; THROMBOCYTE;

ANIMALIA;

EID: 0032775294     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09359.x     Document Type: Conference Paper

References (17)

1. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270: 9856-9861.
2. Raddatz, R. & S. Lanier. 1997. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B. Neurochem. Int. 30: 109-117.
3. 2 sites. J. Pharmacol. Exp. Ther. 272: 681-688.
4. 2-type receptors: Pharmacological characterization and relationship to monoamine oxidase. Br. J. Pharmacol. 109: 625-631.
5. 3H]-idazoxan binding sites. Br. J. Pharmacol. 118: 2029-2036.
6. 2-imidazoline receptors in rat liver. Br. J. Pharmacol. 121: 901-912.
7. Raddatz, R., A. Parini & S. M. Lanier. 1995. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J. Biol. Chem. 270: 27961-27968.
8. 2 with monoamine oxidase-B sites. J. Neurochem. 61: 881-889.
9. 2-adrenergic receptors: Implications tor depression. Crit. Rev. Neurobiol. 9: 26-66.
10. 2-adrenoceptors and monoamine oxidase B in brains of suicide victims. Neurochem. Int. 30: 63-72.
11. 2-imidazoline binding sites and monoamine oxidase activity in human postortem brain from patients with Parkinson's disease. Neurochem. Int. 30: 31-36.
12. Lanier, S. M., B. Ivkovic, I. Singh, J. L. Neumeyer & V. Bakthavachálam. 1993. Visualization of multiple imidazoline/guanidinium-receptive sites. J. Biochem. Mol. Biol. 268: 16047-16051.
13. Ivkovic, B., V. Bakthavachalam, W. Zhang, A. Parini, D. Diz, S. Bosch, J. L. Neumeyer & S. M. Lanier. 1994. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): Intra-tissue distribution of IGRS in liver, forebrain, and kidney. Mol. Pharmacol. 46: 15-23.
14. 2-imidazoline receptor binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 355: 131-138.
15. 3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: Potentiation by tranyleypromine. Life Sci. 60: 605-615.
16. Tesson, F., C. Prip-Buss, A. Lemoine, J.-P. Pegorier & A. Parini. 1991. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. J. Biol. Chem. 264: 11874-11878.
17. 3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of the receptor. Pharmacol. Toxicol. 70: 208-219.